The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p

Abstract

BackgroundMounting evidence demonstrates that long noncoding RNAs (lncRNAs) have critical roles during the initiation and progression of cancers. In this study, we report that the small nucleolar RNA host gene 1 (SNHG1) is involved in colorectal cancer progression.MethodsWe analyzed RNA sequencing data to explore abnormally expressed lncRNAs in colorectal cancer. The effects of SNHG1 on colorectal cancer were investigated through in vitro and in vivo assays (i.e., CCK-8 assay, colony formation assay, flow cytometry assay, EdU assay, xenograft model, immunohistochemistry, and western blot). The mechanism of SNHG1 action was explored through bioinformatics, RNA fluorescence in situ hybridization, luciferase reporter assay, RNA pull-down assay, chromatin immunoprecipitation assay and RNA immunoprecipitation assay.ResultsOur analysis revealed that SNHG1 was upregulated in human colorectal cancer tissues, and high SNHG1 expression was associated with reduced patient survival. We also found that high SNHG1 expression was partly induced by SP1. Moreover, SNHG1 knockdown significantly repressed colorectal cancer cells growth both in vitro and in vivo. Mechanistic investigations demonstrated that SNHG1 could directly interact with Polycomb Repressive Complex 2 (PRC2) and modulate the histone methylation of promoter of Kruppel like factor 2 (KLF2) and Cyclin dependent kinase inhibitor 2B (CDKN2B) in the nucleus. In the cytoplasm, SNHG1 acted as a sponge for miR-154-5p, reducing its ability to repress Cyclin D2 (CCND2) expression.ConclusionsTaken together, the results of our studies illuminate how SNHG1 formed a regulatory network to confer an oncogenic function in colorectal cancer and suggest that SNHG1 may serve as a potential target for colorectal cancer diagnosis and treatment.Electronic supplementary materialThe online version of this article (10.1186/s12943-018-0894-x) contains supplementary material, which is available to authorized users.

MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

“…In addition, several lncRNAs play their roles through competing binding sites of microRNAs, such as HULC [10] and CRNDE [11]. LncRNA SNHG1 can regulate CRC cell growth through interactions with EZH2 [12]. Linc00659 acts as an oncogene in regulating cell growth in CRC by impairing cell cycle progression [13].…”

Long noncoding RNA LINC00630 promotes radio‐resistance by regulating BEX1 gene methylation in colorectal cancer cells

“…Liu et al proposed serous exosomal CRNDE‐h with biomarker potentials for both diagnostic and prognostic purposes in CRC . Xu et al reported that lncRNA SNHG1 modulated CRC cell growth through association with EZH2 and miR‐154‐5p . The investigation performed by Rezanejad et al demonstrated that VIM‐AS1 promoted CRC metastasis and progression by inducing epithelial‐mesenchymal transition process .…”

Long non‐coding small nucleolar RNA host genes in digestive cancers

“…On the contrary, Xu et al confirmed the presence of SNHG1 mainly in the nucleus by performing in situ hybridization and nuclear slurry separation experiments. In the nucleus, SNHG1 combined with protein EZH2 to decrease the epigenetic impact of KLF2 and CDKN2B . Additionally, downregulation of SNHG1 could promote apoptosis and reduce the size and weight of tumors in vivo .…”